flu vaccine for 2023-2024 northern hemisphere influenza season

Category:Intermediates > Pharmaceutical Intermediates
Product Name:flu vaccine for 2023-2024 northern hemisphere influenza season
CAS No.:1
Standard:ChP, In-house Standards
Price(USD):10
Company:Hualan Biological Vaccine Inc.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xinxiang, Henan, China

    Main Sales Markets: Eastern Europe,Asia,Middle East,Africa

  • Monthly Production Capacity: 1000000 vials

    Contract Manufacturing: CRO,CMO

    Packaging Information: in vial or syringe

  • Delivery Lead Time: 1 month

    Sample Provided: no

    Payment Terms: T/T

    flu vaccine for 2023-2024 northern hemisphere influenza season

    [Constituents and Characters]

    The vaccine is approved for use in people aged 3 years old and above, especially in

    vulnerable people and high risk population for influenza complications, such as children, the

    elderly, the weak and people in influenza epidemic areas.

    Active ingredients: Hemagglutinin of prevalent strains of influenza virus in current year.

    Excipients: Na2HPO4, NaH2PO4, NaCl.

    [Strength]

    0.5ml/vial (syringe) Adult

    • an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
    • an A/Darwin/9/2021 (H3N2)-like virus; and
    • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
Send your message to this supplier
  • From:
  • To:
    Hualan Biological Vaccine Inc.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service